
|Articles|September 22, 2022
Greenphire Announces Results From 2022 Annual Market Trends Survey
Advertisement
Greenphire announced results from its 2022 annual market trends survey which examined top challenges and opportunities for sponsors, CROs, and sites across the world. While survey respondents represented a variety of therapeutic areas, including cardiovascular, medical device, rare diseases, infectious diseases and oncology, responses across the board revealed payments as a central concern for all stakeholders.
Read more about the survey results
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
One Clinical: Working Together to Advance Trial Collaboration
2
Syneos Health Expands AI Ecosystem With Three New Platform Partnerships
3
ACT Brief: Data Standardization Bottleneck in Real-Time Monitoring, US Biotech FIH Trial Regulatory Frustration, and FDA Approval of Zenbexus for Multiple Myeloma
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5




